(Press-News.org) A husband and wife research team from Melbourne, Australia, have identified a protein that may be a key
therapy for many inflammatory diseases, including those affecting premature babies.
In the October edition of Nature Immunology, Drs Marcel and Claudia Nold, from the Monash Institute of Medical
Research, describe how a protein, interleukin 37 (IL‐37), reacts when an inflammatory response is detected in the
body.
"Our bodies mount an inflammatory response to protect against an infection, such as bacteria or viruses.
However, if uncontrolled, inflammation can become destructive. IL‐37 is a protein from the cytokine family and is
used by the immune system to regulate the immune response and protect the body from damage caused by
excessive inflammation," said Dr Marcel Nold.
Dr Claudia Nold said that they discovered IL‐37 is one of the rare anti‐inflammatory cytokines that blocks
inflammation throughout the whole body. And, unlike other anti‐inflammatory cytokines, IL‐37 does not target
just one specific inflammatory agent but acts much more broadly.
"We also realised that IL‐37 was activated by a wide range of biological triggers. There are very few cytokines in
the human body that possess these qualities. We believe that potential therapies using IL‐37 could treat a wide
range of diseases in adults and children," she said.
The Nolds' next step is to apply their discovery in models of disease to further understand the protective
properties of IL‐37. One of their first projects will be to investigate the use of IL‐37 to treat chronic lung disease in
babies; a condition that is one of the major causes of mortality and long‐term morbidity in babies born
prematurely.
"Currently, the only way to treat this often fatal disease is to use powerful hormone‐based therapies. While these
can be effective, there is a range of serious side effects, including a return of the disease after cessation of
treatment," said Dr Marcel Nold, who also holds a clinical appointment at Monash Newborn, Southern Health.
"We know this condition is an inflammatory disease, so we are hopeful that by manipulating IL‐37, we may be
able to treat infants before they develop any long term health and developmental problems," he said.
Using models and tissue samples, they will also investigate the role IL‐37 plays in necrotizing enterocolitis, an
often fatal disease in premature babies, where parts of the gut die for reasons that are not clearly understood
and for which no specific treatment exists.
To pursue these goals, Drs Marcel and Claudia Nold will continue their collaboration with the laboratory of
Professor Charles Dinarello at the University of Colorado, Denver, USA, and with Dr Philip Bufler, whose earlier
work on IL‐37 was essential for the success of the project.
"To discover that an obscure cytokine plays a key role in the immune response is a scientist's dream," the Nolds
said. "We hope our work will serve as a foundation on which we can propel IL‐37 to clincial application as fast as
possible."
INFORMATION:
Media queries: Julie Jacobs, Media and Communications Manager: (+613) 9594 7109 / (+61) 429 119 038
Elusive protein may lead the fight against inflammatory disease
2010-10-21
ELSE PRESS RELEASES FROM THIS DATE:
Worst coral death strikes at SE Asia
2010-10-21
International marine scientists say that a huge coral death which has struck Southeast Asian and Indian Ocean reefs over recent months has highlighted the urgency of controlling global carbon emissions.
Many reefs are dead or dying across the Indian Ocean and into the Coral Triangle following a bleaching event that extends from the Seychelles in the west to Sulawesi and the Philippines in the east and include reefs in Sri Lanka, Burma, Thailand, Malaysia, Singapore, and many sites in western and eastern Indonesia.
"It is certainly the worst coral die-off we have seen ...
University of Virginia chemical engineers use gold to discover breakthrough for creating biorenewable chemicals
2010-10-21
October 19, 2010 — University of Virginia chemical engineers Robert J. Davis and Matthew Neurock have uncovered the key features that control the high reactivity of gold nanoparticles in a process that oxidizes alcohols in water. The research is an important first step in unlocking the potential of using metal catalysts for developing biorenewable chemicals.
The scientific discovery could one day serve as the foundation for creating a wide range of consumer products from biorenewable carbon feedstocks, as opposed to the petroleum-based chemicals currently being used as ...
Short-range scattering in quantum dots
2010-10-21
Washington, D.C. (October 19, 2010) -- Chinese researchers, reporting in the Journal of Applied Physics, published by the American Institute of Physics, have described a new breakthrough in understanding the way electrons travel around quantum dots. This might lead to promising new fabrication methods of novel quantum devices.
Guodong Li and colleagues at the National Center for Nanoscience and Technology in Beijing carried out an experiment using self-assembled quantum dots and a two-dimensional electron gas, and then fit the data to a model to find out the type of ...
A forest of nanorods
2010-10-21
WASHINGTON, D.C., (Oct. 20, 2010) -- Just as landscape photographs shot in low-angle light dramatically accentuate subtle swales and mounds, depositing metal vapors at glancing angles turns a rough surface into amazing nanostructures with a vast range of potential properties.
For decades, vapor deposition has been a standard technique for creating modern microelectronic circuits. But nearly all of industry's efforts have been devoted to making structures as flat and smooth as possible. Rather than placing metal sources in the high-noon position used to make featureless ...
'Lubricin' molecule discovered to reduce cartilage wear
2010-10-21
WASHINGTON, D.C., (Oct. 20, 2010) -- A team of researchers in North Carolina has discovered that lubricin, a synovial fluid glycoprotein, reduces wear to bone cartilage. This result, which has implications for the treatment of sufferers of osteoarthritis, will be presented today at the AVS 57th International Symposium & Exhibition, taking place this week at the Albuquerque Convention Center in New Mexico.
Osteoarthritis is the most common form of arthritis, the degenerative joint disease. It mostly affects cartilage, the slippery tissue that covers the ends of bones ...
Measuring changes in rock
2010-10-21
WASHINGTON, D.C., (Oct. 20, 2010) -- The capture and storage of carbon dioxide in deep geologic formations, a strategy for minimizing the impacts of greenhouse gases on global warming, may currently be technologically feasible. But one key question that must be answered is the ability of subsurface materials to maintain their integrity in the presence of supercritical carbon dioxide -- a fluid state in which the gas is condensed at high temperature and pressure into a liquid.
A research team at the Pacific Northwest National Laboratory has developed tools in EMSL, a ...
Rare but deadly virus reveals potential weakness in new study
2010-10-21
PROVIDENCE, R.I. [Brown University] — The JC polyomavirus doesn't strike very often, but it's a mean bug that preys on people with weakened immune systems, including people with AIDS, and almost always kills them. Now an international team of scientists at Brown University, the University of Tübingen in Germany, and Imperial College in London has found a potential Achilles Heel and painted a target on it: The virus must bind to a very specific sugar molecule dangling from the side of the brain cells it attacks.
Like the rebel forces in the 1977 classic movie Star Wars, ...
Neurogenetics research sheds light on the causes of neurological disease
2010-10-21
The last two decades have seen tremendous progress in understanding the genetic basis of human brain disorders. Research developments in this area have revealed fundamental insights into the genes and molecular pathways that underlie neurological and psychiatric diseases. In a new series of review articles published by Cell Press in the October 21 issue of the journal Neuron, experts in the field discuss exciting recent advances in neurogenetics research and the potential implications for the treatment of these devastating disorders.
Genetic discoveries have transformed ...
Gene therapy may be powerful new treatment for major depression
2010-10-21
NEW YORK (Oct. 20, 2010) -- In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.
The researchers hope to rapidly translate their findings into a human clinical trial using the same kind of gene therapy modality the investigators have pioneered to treat Parkinson's disease. A 45-patient randomized blinded phase II ...
Surgical aortic valve replacement should remain the standard treatment for aortic stenosis
2010-10-21
(Boston) - Despite the promising results of the "Placement of Aortic Transcatheter Valves (PARTNER) trial," featured in the Oct. 21 issue of the New England Journal of Medicine, a cardiothoracic surgeon from Boston Medical Center (BMC) believes that surgical aortic-valve replacement should remain the standard treatment of aortic stenosis. In the accompanying editorial, the author argues that Transcatheter aortic-valve implantation (TAVI) should be reserved for patients at inordinately high risk who are not suitable candidates for surgery and who have decreased life expectancy. ...